SCHEMBL1129264

SCHEMBL1129264

CC(C)(Cl)c1nc2cc(F)ccc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ SCN10A Q9Y5Y9 2/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ AR P10275 1/20 0.36
▸ ALPL P05186 1/20 0.35
▸ ALPI P09923 1/20 0.35
▸ ALPG P10696 1/20 0.35
▸ AHR P35869 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2732982 0.86 ALDH1A1 (0.45) NPSR1KDM4EMAPTHPGDPOLB
SCHEMBL2241014 0.86 NPSR1 (0.41) NPSR1KDM4EMAPTHPGDPOLB
SCHEMBL1129051 0.81 KMT2A (0.40) NPSR1KDM4EMAPTHPGDPOLB
SCHEMBL10847755 0.73 ALPL (0.35) NPSR1KDM4EMAPTHPGDPOLB
SCHEMBL2008567 0.73 TYMS (0.49) KDM4EMAPTHPGDPOLBALDH1A1
SCHEMBL1747974 0.73 KDM4E (0.42) KDM4EMAPTHPGDALDH1A1CYP1A2
SCHEMBL10220066 0.72 ALDH1A1 (0.56) KDM4EMAPTHPGDALDH1A1CYP1A2
SCHEMBL1835419 0.72 ALPL (0.51) KDM4EMAPTHPGDALDH1A1CYP1A2
SCHEMBL1170649 0.72 KDM4E (0.52) NPSR1KDM4EHPGDALDH1A1CYP1A2
SCHEMBL13319134 0.72 IDO1 (0.45) KDM4EMAPTPOLBCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282762-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION Intermune, Inc. (US) 2011-02-16 — — EP disclosed
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 — — WO disclosed
Send feedback